Virological Failure and Drug Resistance in Patients on Antiretroviral Therapy After Treatment Interruption in Lilongwe, Malawi | Zendy

James F. Luebbert | Zendy; Hannock Tweya | Zendy; Sam Phiri | Zendy; Thom Chaweza | Zendy; Johnbosco Mwafilaso | Zendy; M. C. Hosseinipour | Zendy; Heribert Ramroth | Zendy; Paul Schnitzler | Zendy; Florian Neuhann | Zendy

Open Access

Virological Failure and Drug Resistance in Patients on Antiretroviral Therapy After Treatment Interruption in Lilongwe, Malawi

Author(s) -

James F. Luebbert,

Hannock Tweya,

Sam Phiri,

Thom Chaweza,

Johnbosco Mwafilaso,

M. C. Hosseinipour,

Heribert Ramroth,

Paul Schnitzler,

Florian Neuhann

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis438

Subject(s) - medicine , drug resistance , reverse transcriptase inhibitor , genotyping , viral load , drug holiday , reverse transcriptase , protease inhibitor (pharmacology) , antiretroviral therapy , hiv drug resistance , virology , genotype , human immunodeficiency virus (hiv) , pediatrics , polymerase chain reaction , biochemistry , chemistry , gene , microbiology and biotechnology , biology

Since 2004, Malawi has rapidly scaled up access to antiretroviral therapy (ART) in the national program following a public health approach with limited laboratory monitoring. We examined virological outcomes in patients with treatment interruption at 2 clinics of the Lighthouse Trust, Lilongwe, Malawi.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research